Results 121 to 130 of about 16,620 (187)

Quality of reporting and risk of bias: a review of randomised trials in occupational health. [PDF]

Occup Environ Med, 2021
Tikka C, Verbeek J, Ijaz S, Hoving JL, Boschman J, Hulshof C, de Boer AG.   +6 more
europepmc   +1 more source

Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study. [PDF]

Adv Ther
Lebwohl MG, Koo JY, Jaworski J, Trefler J, Daniluk S, Dudek A, Baran W, Owczarek W, Kolinek J, Brzewski P, Sikora M, Krogulec M, Kim S, Bae Y, Jeon D, Choi E, Cha J, Lee H, Choi S, Pariser DM.   +19 more
europepmc   +1 more source

The 100 most-cited articles in COVID-19: a bibliometric analysis. [PDF]

Eur J Public Health
Liew YY, Dong Q, Lakshman N, Khajuria A.
europepmc   +1 more source

May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland. [PDF]

Eur Heart J Suppl, 2020
Jankowski P, Banach M, Małyszko J, Mastej M, Tykarski A, Narkiewicz K, Hoffman P, Nowicki MP, Tomasik T, Windak A, Olszanecka A, Tomaszewskil M, Motyl A, Nowak D, Skowron Ł, Beaney T, Ster AC, Xin X, Poulter NR, Jóźwiak J.   +19 more
europepmc   +1 more source

Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study. [PDF]

Arthritis Res Ther, 2021
Kay J, Jaworski J, Wojciechowski R, Wiland P, Dudek A, Krogulec M, Jeka S, Zielinska A, Trefler J, Bartnicka-Maslowska K, Krajewska-Wlodarczyk M, Klimiuk PA, Lee SJ, Bae YJ, Yang GE, Yoo JK, Furst DE, Keystone E.   +17 more
europepmc   +1 more source

Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis. [PDF]

Rheumatology (Oxford), 2022
Furst DE, Jaworski J, Wojciechowski R, Wiland P, Dudek A, Krogulec M, Jeka S, Zielinska A, Trefler J, Bartnicka-Maslowska K, Krajewska-Wlodarczyk M, Klimiuk PA, Lee SJ, Kim SH, Bae YJ, Yang GE, Yoo JK, Kay J, Keystone E.   +18 more
europepmc   +1 more source

Стан імунної системи у хворих на ВІЛ-інфекцію/СНІД під впливом антиретровірусної терапії [PDF]

, 2013
Баланюк, І.В., Возна, Х.І., Меленко, С.Р., Москалюк, В.Д., Сорохан, В.Д.   +4 more
core  

Psychological Contract Breach and Outcomes: A Systematic Review of Reviews. [PDF]

Int J Environ Res Public Health, 2022
Topa G, Aranda-Carmena M, De-Maria B.
europepmc   +1 more source

Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance. [PDF]

Rheumatol Ther
Batko B, Jeka S, Wiland P, Zielińska A, Stopińska-Polaszewska M, Stajszczyk M, Kosydar-Piechna M, Cadatal MJ, Rivas JL.   +8 more
europepmc   +1 more source

The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation. [PDF]

Postepy Dermatol Alergol, 2020
Góralczyk A, Kolossa K, Waszczak-Jeka M, Adamczak R, Jeka S.   +4 more
europepmc   +1 more source